查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606442

帶狀皰疹疫苗市場，按產品類型、按疫苗類型、按應用、按國家和地區 - 2024-2032 年行業分析、市場應用、市場佔有率和預測

Shingles Vaccine Market, By Product Type, By Vaccine Type, By Application, By Country, and By Region - Industry Analysis, Market Application, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年帶狀皰疹疫苗市場應用價值為42.5943億美元，2024年至2032年複合年成長率為15.50%。

帶狀皰疹疫苗市場-市場動態

人們對帶狀皰疹的認知不斷提高，免疫功能低下疾病的發生率不斷上升，預計將推動市場需求

糖尿病、癌症、愛滋病毒/愛滋病盛行率的增加以及免疫抑制藥物的使用增加了帶狀皰疹的易感性，增加了高風險族群接種疫苗的需求，從而推動了市場的成長。醫療機構進行的宣傳活動強調帶狀皰疹及其嚴重併發症（例如帶狀皰疹後神經痛 (PHN)）的風險，並鼓勵人們接種疫苗。疾病預防控制中心和國家衛生部門進行教育活動，促進老年人接種帶狀皰疹疫苗。據世界衛生組織稱，到 2050 年，全球 60 歲及以上人口預計將增加一倍，目標人口規模大幅擴大。

疫苗技術的進步預計也將促進市場成長。 Shingrix（一種重組帶狀皰疹疫苗）的開發等創新提高了疫苗的功效和安全性，鼓勵人們採用 Zostavax 等較舊的減毒活疫苗。最近，COVID-19 大流行凸顯了疫苗在預防傳染病方面的重要性，激發了人們對包括帶狀皰疹在內的其他關鍵疫苗的興趣。

帶狀皰疹疫苗市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 15.50% 左右的複合年成長率成長

根據產品類型細分，由於不良事件的有效性，Shingrix 細分市場預計將在 2023 年顯示最大的市場佔有率。

根據疫苗類型細分，由於在病毒株中的應用更廣泛，重組疫苗細分市場將成為 2023 年領先的疫苗類型細分市場。

根據應用細分，藥物傳輸領域是 2023 年領先的應用領域，這主要是由於疫苗接種計劃的採用不斷增加。

從地區來看，由於頂級市場參與者的存在，北美是 2023 年的主要收入來源。

帶狀皰疹疫苗市場-細分分析：

全球帶狀皰疹疫苗市場根據產品類型、疫苗類型、應用和地區進行細分。

根據產品類型，市場分為三類：Shingrix、Zostavax 和 SKYZoster。 Shingrix 細分市場佔據主導地位。由於成本效益高，SKYZoster 業務預計將以最快的速度成長。

市場依疫苗類型分為兩類：重組疫苗和減毒活疫苗。重組疫苗領域佔據市場主導地位。隨著重組 DNA 技術的採用，這些疫苗的需求不斷成長。

市場依應用分為三類：研究、藥物傳遞和其他。藥物傳輸領域在全球市場佔據主導地位。疫苗提供持久免疫力和藥物輸送效率的能力預計將促進該細分市場的成長。

帶狀皰疹疫苗市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。由於強大的醫療基礎設施、高認知度以及 Shingrix 等疫苗的大量使用，北美在帶狀皰疹疫苗市場上佔據主導地位。歐洲是第二大市場，在英國、德國和法國等國家廣泛採用。歐洲疾病預防與控制中心（ECDC）加大力度協調疫苗接種政策預計將推動市場成長。由於醫療保健服務的改善、可支配收入的增加以及老年人口的增加，亞太地區正在經歷快速成長。

帶狀皰疹疫苗市場-競爭格局：

在人們意識的提高、帶狀皰疹發病率上升以及政府支持的疫苗接種計劃的推動下，帶狀皰疹疫苗市場競爭非常激烈。全球市場由幾家主要參與者主導，其中葛蘭素史克 (GSK) 和默克公司處於領先地位。葛蘭素史克 (GSK) 的 Shingrix 疫苗擁有巨大的市場佔有率，這主要是由於其高效性以及越來越多的老年人推薦使用該疫苗。該公司正在投資基於 mRNA 的疫苗，其他一些重要參與者包括 SK Chemicals 和 Green Cross Corp，它們正在推出創新疫苗。

2024年4月，葛蘭素史克公佈了ZOSTER-049試驗的結果，該試驗顯示Shingrix有效保護了50歲以上的人。

2023 年 2 月，輝瑞和 BioNTech 開始試驗以 mRNA 為基礎的帶狀皰疹疫苗。

目錄

第1章：帶狀皰疹疫苗市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 帶狀皰疹疫苗市場片段（依產品類型）
    • 帶狀皰疹疫苗市場片段（依疫苗類型）
    • 帶狀皰疹疫苗市場片段（按應用）
    • 帶狀皰疹疫苗市場片段（按國家/地區）
    • 帶狀皰疹疫苗市場片段（按地區）
  • 競爭洞察

第 3 章：帶狀皰疹疫苗主要市場趨勢

  • 帶狀皰疹疫苗市場促進因素
    • 市場促進因素的影響分析
  • 帶狀皰疹疫苗市場限制
    • 市場限制影響分析
  • 帶狀皰疹疫苗市場機會
  • 帶狀皰疹疫苗市場未來趨勢

第 4 章：帶狀皰疹疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：帶狀皰疹疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：帶狀皰疹疫苗市場格局

  • 2023 年帶狀皰疹疫苗市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：帶狀皰疹疫苗市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 欣格里克斯
    • 佐斯塔瓦克斯
    • 天空佐斯特

第 8 章：帶狀皰疹疫苗市場 - 按疫苗類型

  • 概述
    • 按疫苗類型分類的細分市場佔有率分析
    • 重組疫苗
    • 減毒活疫苗

第 9 章：帶狀皰疹疫苗市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 研究
    • 藥物輸送
    • 其他

第 10 章：帶狀皰疹疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美帶狀皰疹疫苗主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按疫苗類型）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲帶狀皰疹疫苗主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按疫苗類型）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區帶狀皰疹疫苗主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（依疫苗類型）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲帶狀皰疹疫苗主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按疫苗類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲帶狀皰疹疫苗主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按疫苗類型）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 帶狀皰疹疫苗產業

  • 競爭儀表板
  • 公司簡介
    • GlaxoSmithKline (GSK)
    • Merck & Co., Inc.
    • Pfizer Inc.
    • SK Chemicals
    • Green Cross Corp
    • Geneone Life Science
    • Vaccitech
    • CanSinoBIO
    • Jiangsu Recbio Technology Co., Ltd.
    • MedImmune LLC
    • AbbVie Inc.
    • Sanofi Pasteur
    • VBI Vaccines Inc.
    • Novavax Inc.
    • Bavarian Nordic
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4239

REPORT HIGHLIGHT

Shingles Vaccine Market Application was valued at USD 4,259.43 Million in 2023, expanding at a CAGR of 15.50% from 2024 to 2032.

The shingles vaccine is a medical intervention designed to reduce the risk of developing shingles (herpes zoster), a painful rash caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox. Shingles predominantly affects older adults or individuals with weakened immune systems. The vaccine not only decreases the likelihood of shingles but also reduces the severity and duration of symptoms.

Shingles Vaccine Market- Market Dynamics

Increasing awareness about shingles and rising incidence of immunocompromising disorders is expected to propel market demand

Increasing prevalence of diabetes, cancer, HIV/AIDS, and the use of immunosuppressive drugs increase susceptibility to shingles, boosting the need for vaccination among at-risk groups, thereby fueling market growth. Awareness campaigns by healthcare organizations emphasize the risks of shingles and its severe complications, such as postherpetic neuralgia (PHN), encouraging vaccine uptake. The CDC and national health departments run educational initiatives promoting shingles vaccination among older adults. According to WHO, the global population aged 60 and above is expected to double by 2050, significantly expanding the target demographic.

Advancement in vaccine technology is also projected to enhance market growth. Innovations such as the development of Shingrix (a recombinant zoster vaccine) have improved vaccine efficacy and safety, encouraging adoption over older live-attenuated vaccines like Zostavax. Recently, the COVID-19 pandemic highlighted the importance of vaccines in preventing infectious diseases, spurring interest in other critical vaccines, including shingles.

Shingles Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.50% over the forecast period (2024-2032)

Based on Product Type segmentation, the Shingrix segment was predicted to show maximum market share in the year 2023, owing to effectiveness in adverse events.

Based on Vaccine Type segmentation, the recombinant vaccine segment was the leading Vaccine Type segment in 2023, due to wider applications in virus strains.

Based on Application segmentation, the drug delivery segment was the leading Application segment in 2023, mainly due to the rising adoption of vaccination programs.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of top market players.

Shingles Vaccine Market- Segmentation Analysis:

Global Shingles Vaccine Market is segmented on the basis of Product Type, Vaccine Type, Application, and Region.

The market is divided into three categories based on the Product Type: Shingrix, Zostavax, and SKYZoster. The Shingrix segment dominates the market. The SKYZoster segment is estimated to grow at the fastest rate due to its high cost-effectiveness.

The market is divided into two categories based on Vaccine Type: recombinant vaccine and live attenuated vaccine. The recombinant vaccine segment dominates the market. With the adoption of recombinant DNA technology these vaccines are growing in demand.

The market is divided into three categories based on Application: research, drug delivery, and others. The drug delivery segment dominates the global market. The vaccines' ability to provide long-lasting immunity & efficiency in drug delivery is expected to boost segment growth.

Shingles Vaccine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the shingles vaccine market, driven by strong healthcare infrastructure, high awareness, and significant uptake of vaccines like Shingrix. Europe is the second-largest market, with robust adoption in countries like the UK, Germany, and France. Increased efforts by the European Centre for Disease Prevention and Control (ECDC) to harmonize vaccination policies are expected to boost market growth. Asia-Pacific is experiencing rapid growth due to improved healthcare access, rising disposable incomes, and a growing elderly population.

Shingles Vaccine Market- Competitive Landscape:

The shingles vaccine market is highly competitive, driven by increasing awareness, rising incidence of shingles, and government-backed vaccination programs. The global market is dominated by a few key players, with GlaxoSmithKline (GSK) and Merck & Co. leading the field. GSK's Shingrix vaccine has a significant market share, largely due to its high efficacy and the growing recommendation for its use among older adults. Companies are investing in mRNA-based vaccines with some other significant players include SK Chemicals and Green Cross Corp, which are introducing innovative vaccines.

In April 2024, GSK showed results from the ZOSTER-049 trial, which disclosed that Shingrix effectively protected people aged above 50.

In February 2023, Pfizer & BioNTech started trials for mRNA-based shingle vaccines.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SHINGLES VACCINE MARKET KEY PLAYERS

  • GlaxoSmithKline (GSK)
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SK Chemicals
  • Green Cross Corp
  • Geneone Life Science
  • Vaccitech
  • CanSinoBIO
  • Jiangsu Recbio Technology Co., Ltd.
  • MedImmune LLC
  • AbbVie Inc.
  • Sanofi Pasteur
  • VBI Vaccines Inc.
  • Novavax Inc.
  • Bavarian Nordic
  • Others

GLOBAL SHINGLES VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Shingrix
  • Zostavax
  • SKYZoster

GLOBAL SHINGLES VACCINE MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019-2032

  • Recombinant vaccine
  • Live attenuated vaccine

GLOBAL SHINGLES VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Research
  • Drug delivery
  • Others

GLOBAL SHINGLES VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Shingles Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Shingles Vaccine Market Snippet by Product Type
    • 2.1.2. Shingles Vaccine Market Snippet by Vaccine Type
    • 2.1.3. Shingles Vaccine Market Snippet by Application
    • 2.1.4. Shingles Vaccine Market Snippet by Country
    • 2.1.5. Shingles Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Shingles Vaccine Key Market Trends

  • 3.1. Shingles Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Shingles Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Shingles Vaccine Market Opportunities
  • 3.4. Shingles Vaccine Market Future Trends

4. Shingles Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Shingles Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Shingles Vaccine Market Landscape

  • 6.1. Shingles Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Shingles Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Shingrix
    • 7.1.3. Zostavax
    • 7.1.4. SKYZoster

8. Shingles Vaccine Market - By Vaccine Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
    • 8.1.2. Recombinant vaccine
    • 8.1.3. Live attenuated vaccine

9. Shingles Vaccine Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Research
    • 9.1.3. Drug delivery
    • 9.1.4. Others

10. Shingles Vaccine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Shingles Vaccine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Shingles Vaccine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Shingles Vaccine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Shingles Vaccine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Shingles Vaccine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Shingles Vaccine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GlaxoSmithKline (GSK)
    • 11.2.2. Merck & Co., Inc.
    • 11.2.3. Pfizer Inc.
    • 11.2.4. SK Chemicals
    • 11.2.5. Green Cross Corp
    • 11.2.6. Geneone Life Science
    • 11.2.7. Vaccitech
    • 11.2.8. CanSinoBIO
    • 11.2.9. Jiangsu Recbio Technology Co., Ltd.
    • 11.2.10. MedImmune LLC
    • 11.2.11. AbbVie Inc.
    • 11.2.12. Sanofi Pasteur
    • 11.2.13. VBI Vaccines Inc.
    • 11.2.14. Novavax Inc.
    • 11.2.15. Bavarian Nordic
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us